Professionals 202 Users Online

Complex Injectable Market

Complex Injectable Market: Global Industry Trend Analysis 2012 to 2017 and Forecast 2017 - 2025

Complex Injectable Market Segmented By application such as Cancer, Diabetes, CNS, Infections, Cardiovascular Diseases and Musculoskeletal with Route of administration such as Intravenous(IV), Intramuscular(IM) and Subcutaneous(SC)

Market Overview

Complex injectable are designed to infuse drug through a hollow needle and a syringe which is penetrated through the skin into the body. Complex injectable market is gaining traction in the injectable therapies/infusion treatment owing to increase in use in life-threatening and chronic diseases treatments.

The manufacturing of the complex injectable products is extremely complex and requires major investment. Since the injectables are highly toxic and infectious in nature, therefore a great level observation of quality and care is required during their manufacturing, packaging, distribution and storage.

From the last few years it is observed that many pharmaceutical companies are adopting mergers and acquisition as strategy to penetrated into global complex injectable market. The increase attention in biologics and targeted treatments has led to an increase in the necessity for injectable drugs, specifically in the area of cancer.

In many countries, injectable forms are very common and are widely used in health services for minor symptoms. There are different types of injections designed to inject complex injectable into the body and some of them are intradermal injections, intramuscular injections and subcutaneous injections. The biological drugs have a larger part of the complex injectable market.

The global complex injectable market is witnessing supply shortages.  The competition in complex injectable market is relatively less because injectable products are complex in nature and require high capital investment for plant establishment.

Growth in the complex injectable market are mainly driven by the generic injectables. Across the globe, researchers have found that North America, Europe, and Asia Pacific are the major players which are operating in the global complex injectable market. 

Market for complex injectable is primarily driven by the rising incidence of chronic diseases, increase in the demand for self-injection devices, technological advancements challenges, stability of the product when combined with other products, growth of biologics market, preference of other modes of drug delivery. Increase number of needle-stick infections is the restraint for the injectable market.

The global market for complex injectable is segmented on basis of application, route of administration, molecule type, distribution channel, formulation packaging, usage pattern, site of administration, end user and geography.

by application
  • Cancer
  • Diabetes
  • CNS
  • Infections
  • Cardiovascular Diseases
  • Musculoskeletal
by Route of administration
  • Intravenous(IV)
  • Intramuscular(IM)
  • Subcutaneous(SC)
by formulation packaging
  • Bottles
  • Vials
  • Ampules
  • Cartridges
by end user
  • Hospitals and clinics
  • Home Care Settings
  • Online Pharmacies
  • Others

Based on formulation packaging, the complex injectable market is segmented into the ampules, vials, bottles and cartridges. Amongst them ampules are expected to dominate the market due to its good barrier properties. Factors like ease of transportation and low cost of manufacturing are driving the growth in this segment.

On the basis of geography, complex injectable market is segmented into five key regions viz. North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. According to the report published by CDC, North America is expected to dominate the market due to the increasing prevalence of chronic diseases. Asia is projected to be the fastest-growing region in the complex injectable market due to the rising incidence of chronic diseases and the growing aging population.

Some of the key players in complex injectable market are Eli Lilly And Company, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Hospira, Hikma Pharmaceutical Company, Johnson & Johnson pharmaceutical company, Novo Nordisk, Abbvie.

Sample Report

FREE Report Sample is Available

In-depth report coverage is now just a few seconds away

Download PDF Get FREE Report Sample

The report covers exhaustive analysis on:

  • Complex Injectable Market Segments
  • Complex Injectable Market Dynamics
  • Historical Actual Market Size, 2012 - 2016
  • Complex Injectable Market Size & Forecast 2017 to 2025
  • Complex Injectable Market Current Trends/Issues/Challenges
  • Competition & Companies Involved
  • Complex Injectable Market Drivers And Restraints
Custom Report Cover

Make This Report Your Own

Take Advantage of Intelligence Tailored to your Business Objective

> Get a Customized Version

Regional analysis includes

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa
Market Research Methodology

Market Research Methodology

-Perfect through Years of Diligence

Check Research Methodology

Report Highlights:

  • Shifting Industry dynamics
  • In-depth market segmentation
  • Historical, current and projected industry size Recent industry trends
  • Key Competition landscape
  • Strategies of key players and product offerings
  • Potential and niche segments/regions exhibiting promising growth
  • A neutral perspective towards market performance
Sales Team

Sales Team
Client Partner

Let's Connect

Connect me to identify winning opportunities

Ask An Expert
I'm Available

- Companies Covered in This Report -

This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy
Google translate